I checked our download records for "The Big Beautiful Bubble Report" and didn't see your name.
That concerns me.
With the national debt hitting $38 trillion and growing $8 billion daily, this intelligence report is more critical than ever. But we may have to take it down soon.
Why?
The report exposes how Trump's $3 trillion spending bill created an artificial bubble in your 401(k).
It reveals why your "safe" retirement investments are actually the riskiest.
It shows the precious metals strategy that protects wealth when fake money systems collapse.
If you want your financial future protected, add your name to the list.
Once we pull this report, it's gone. No re-releases. No second chances.
Download The Big Beautiful Bubble Report FREE
To your safe retirement,
Shanon Davis
CEO, American Alternative Assets
Wall Street Loves FIGS—Why Do Price Targets Predict Pullback?
Written by Jennifer Ryan Woods. Originally Published: 3/4/2026.
Key Points
- FIGS stock has surged nearly 260% over the past year, hitting a price not seen since shortly after its 2021 IPO.
- Q4 revenue topped $200 million—the company's best quarter ever—with scrubwear sales up 35% and international sales jumping 55%.
- Despite the rally and bullish analyst commentary, the consensus price target sits almost 30% below current levels.
- Special Report: [Sponsorship-Ad-6-Format3]
After a stunning plunge following its 2021 IPO, medical and lifestyle apparel company FIGS, Inc. (NYSE: FIGS) has roared back to life, trading at a price it hasn't seen in nearly four years. The stock, now above $17, has surged almost 260% over the past year, including a 58% jump in the last month.
The rally has been driven by strong earnings and a wave of bullish analyst commentary. Yet despite the momentum, the consensus 12‑month price target sits at just $12.25—nearly 30% below the current price. That gap raises the question: how much of FIGS' recovery is supported by fundamentals, and how much is momentum?
Elon Musk already made me a "wealthy man" (Ad)
I Met Elon Musk "Face-to-Face"
During a private gathering of Wall Street elites, I was one of two people selected to speak with Elon personally.
As a result, my research now leads me to believe Elon will announce the SpaceX IPO on this date:
March 26, 2026. Circle it on your calendar.
I'm sharing an "access code" that lets anyone grab a pre-IPO stake before it happens. This is your invitation to the biggest wealth-building event of the decade.
Early investors in FIGS enjoyed quick gains after the company's May 2021 IPO priced at $22 per share; within a month the shares climbed to about $50. The COVID‑19 pandemic had boosted demand for medical apparel, but as the pandemic eased the shares reversed course and within a year fell below $8. In the years that followed FIGS mostly traded in the single digits, and after dipping below $4 in April 2025 the stock began another upward run.
Earnings Momentum Sparks Rally
Following steady gains after its Q1 and Q2 2025 reports, FIGS' Q3 2025 results, released Nov. 6, accelerated the rally. The quarter showed stronger‑than‑expected revenue growth, solid demand across core categories and healthy margins despite tariff headwinds.
The company also raised its full‑year guidance for net revenue and adjusted EBITDA margins. Wall Street responded favorably: the stock climbed more than 30% over the following week, and Zacks Research upgraded the shares to Strong Buy from Hold.
The momentum continued after the Q4 2025 earnings report on Feb. 26. The quarter delivered a 33% revenue increase and marked FIGS' strongest quarterly sales yet, topping $200 million. On the earnings call, management highlighted growth in the active customer base and higher average order values; the company also gained visibility by outfitting Team USA's medical team at the Winter Olympics.
Scrubwear—the company's core segment, accounting for more than three‑quarters of net revenue—grew 35%, while international sales rose 55%. The fourth quarter capped a solid year: net revenue for the full year reached a record $630 million, up 14% year‑over‑year. Despite tariff pressures that compressed gross margins, profitability remained strong, with full‑year adjusted EBITDA margin exceeding targets by more than 200 basis points.
Analysts Applaud Earnings and Outlook
FIGS issued an upbeat outlook for the year ahead, citing continued demand backed by growth in healthcare jobs, plans to expand into new international markets, prioritized growth initiatives across businesses and a continued stock buyback program.
For fiscal 2026, management expects net revenue growth of 10%–12% with improving profitability targets.
Analysts responded with a string of upgrades and target changes. Barclays moved to Strong Buy from Hold, KeyCorp shifted to Overweight from Sector Weight with a $17 target, and Goldman Sachs moved its rating to Hold from Strong Sell. BTIG reiterated a Buy rating with a $15 target, and Telsey Advisory raised its target to $15 from $9.
FIGS Stock Pushes Past Price Targets
FIGS' earnings momentum is the clear catalyst behind the push to four‑year highs. Shares began rising even before the Q4 report, jumping nearly 14% in the session ahead of the release. After the results, the rally intensified: the stock gained 24% on the first trading day following the report and added another 10% the next day. As of March 4, the stock was trading above $17, well above Morgan Stanley's $8 target issued in January and at or above many of the firms that recently raised their targets.
The disparity between bullish analyst commentary and relatively modest price targets suggests caution: analysts appear to appreciate FIGS' improving fundamentals but remain wary of the stock's valuation. At current levels, shares trade at a price‑to‑earnings ratio near 90, implying much of the company's expected growth may already be priced in.
There are few publicly traded direct competitors to FIGS. By contrast, lululemon athletica inc. (NASDAQ: LULU), a dominant player in lifestyle apparel, trades at a P/E of less than 12 (MarketBeat comparison). The bottom line: investors are cheering the turnaround, but skepticism remains about whether the stock can sustain its run or if a pullback is likely.
3 Unique ETFs Launched in 2026 to Vary Your Investment Strategy
By Nathan Reiff. Posted: 3/1/2026.
Key Points
- Three brand-new ETFs launched in 2026 all include unique strategies with a passive income component.
- Although investors will pay as much as 1.14% in annual fees for funds including MEMY, ISSB, and ONEH, their distinctive approach to combining multiple angles may appeal.
- These funds all have very low asset bases, as they are just weeks into public trading, increasing the overall risk to individual investors—but they also may have significant untapped potential to provide a combination of returns and income.
- Special Report: [Sponsorship-Ad-6-Format3]
Investors pursuing a first-to-market strategy may welcome the steady flow of new exchange-traded funds (ETFs). With more than 1,100 new ETFs launching in 2025, last year offered ample opportunity to get in early on upstart funds and potentially capture outsized growth over time. 2026 shows no signs of slowing, as investors continue to funnel hundreds of billions of dollars per month into exchange-traded products.
Of course, new ETFs also introduce risks: limited liquidity, no long track record, and, in many cases, fund managers investors may not know well. The funds below use distinctive strategies that may appeal to some investors, but it's important to keep those caveats in mind before exploring any brand-new ETF. For investors comfortable with the risks, the potential rewards can be meaningful.
A Strategy Combining Meme Stock Exposure With Weekly Distributions
Elon Musk already made me a "wealthy man" (Ad)
I Met Elon Musk "Face-to-Face"
During a private gathering of Wall Street elites, I was one of two people selected to speak with Elon personally.
As a result, my research now leads me to believe Elon will announce the SpaceX IPO on this date:
March 26, 2026. Circle it on your calendar.
I'm sharing an "access code" that lets anyone grab a pre-IPO stake before it happens. This is your invitation to the biggest wealth-building event of the decade.
The meme stock phenomenon persists, and more ETFs are targeting companies that have gone viral. The Tuttle Capital Meme Stock Income Blast ETF (BATS: MEMY) is the latest fund to explore this niche, aiming to provide both income and exposure to speculative meme stocks.
MEMY invests at least 80% of its assets in meme stocks, identifying potential targets via social media and retail investor forums, then selecting names based on short interest, options trade history, and unusual price movement. The fund favors stocks with elevated implied volatility, which it intends to exploit with options strategies to generate income.
It targets a portfolio of 15 to 30 U.S.-listed stocks across sectors and market caps and uses put credit spreads to deliver weekly distributions to shareholders.
Given the high volatility of meme stocks, the regular income component can help buffer downside risk for investors who want exposure but are concerned about unpredictable price swings.
For its complex strategy and active management, MEMY carries an expense ratio of 0.99%. Like many newly launched ETFs, it currently has very low assets under management (AUM).
One Fund Combining Exposure to Large-Cap U.S. Stocks and Bitcoin With Added Income Incentive
The IncomeSTKd 1X US Stocks & 1X Bitcoin Premium ETF (BATS: ISSB) is another fund targeting weekly distributions, but with a broader, more layered approach. ISSB invests in futures and other derivatives tied to large-cap S&P 500 stocks and Bitcoin-related derivatives, prioritizing total return. It also seeks tax efficiency through specialized options strategies.
ISSB builds income by harvesting option premiums, a method that can benefit from market volatility. That makes the fund complex and multi-faceted.
As a result, ISSB aims to appeal to investors seeking supplementary income, those looking for indirect Bitcoin exposure, and investors bullish on large-cap U.S. stocks.
Because of its broad and complicated strategy, this actively managed ETF carries a higher price tag: an expense ratio of 1.14%.
Downside Protection With an Income Bonus
The lowest-cost fund on this list (expense ratio 0.79%) and the largest by AUM (nearly $14 million) is the TrueShares Equity Hedge ETF (BATS: ONEH). ONEH may appeal to investors expecting broader market weakness: it invests in both put and call options on the S&P 500, positioning the fund to potentially gain in a variety of decline scenarios as well as in some positive-return situations.
ONEH also includes an income component funded by a diversified sleeve of income-producing securities, including U.S. Treasuries, government and corporate bonds, collateralized loan obligations (CLOs), preferred stock, and more. The fund has not yet begun distributions, given its recent launch, but intends to pay out at least annually.
Like the other funds profiled, ONEH employs a complex strategy that may not suit all investors.
At its core, the fund is designed to provide equity exposure with a built-in downside hedge and a reallocation feature to support upside recoveries when they occur.
Despite its lower expense ratio and larger AUM relative to the other funds here, ONEH remains more specialized—and smaller—than many mainstream ETFs. Investors should consider it a higher-risk, niche option and weigh those factors against their broader portfolio needs.
This email content is a paid sponsorship for American Alternative, a third-party advertiser of InsiderTrades.com and MarketBeat.
If you have questions about your newsletter, please contact our South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from InsiderTrades.com, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC. All rights protected.
345 North Reid Place, Suite 620, Sioux Falls, South Dakota 57103-7078. USA..